Abstract: In modern software development, it is common to select and use an appropriate programming language according to the purpose and application. Julia is attracting attention as a language that ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

AI can help design AI systems: automating architecture choices, discovering algorithms, and optimizing hardware ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

DNA Ginkgo Bioworks Holdings, Inc.

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Terms apply to American Express benefits and offers. Visit americanexpress.com to learn more. Any time you tap, swipe or dip a credit or debit card at checkout or enter your card number online, you ...

A new research paper reframes the simulation hypothesis, asking whether reality could be simulated and what science can test.

Explore the alarming rise of kidnappings in South Africa and the profound psychological trauma that victims endure, as well ...

National security, unlocked. Each Thursday, host Mary Louise Kelly and a team of NPR correspondents discuss the biggest national security news of the week. With decades of reporting from battlefields ...